MedTrace Logo

AD-SVF Therapy for Refractory Endometrial Infertility

NCT07230600 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-11-18

No results posted yet for this study

Summary

The purpose of this study is to initially explore the efficacy of adipose-derived stromal vascular fraction (AD-SVF) therapy in the treatment of refractory endometrial infertility.

Conditions

  • Endometrium; Atrophy
  • Intrauterine Synechiae

Interventions

BIOLOGICAL

AD-SVF

AD-SVF is isolated and extracted from adipose tissue for intrauterine infusion therapy.

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Principal Investigators

  • Yali Hu · The Affiliated Drum Tower Hospital of Nanjing University

  • Huiyan Wang · The Affiliated Drum Tower Hospital of Nanjing University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-30
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07230600 on ClinicalTrials.gov